Our results are in line with the above studies, and furthermore our logistic regression results showed that subjects in the fourth quartile of the ApoB/ApoA1 ratio had a 24.48-fold increased risk of MetS than the first quartile even after adjusting for confounding factors. The gene discussed is APOB; the disease is metabolic syndrome.